Table of Contents

2019-2024 Global Joint Pain Injections Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Joint Pain Injections Consumption 2014-2024
  • 2.1.2 Joint Pain Injections Consumption CAGR by Region
• 2.2 Joint Pain Injections Segment by Type
  • 2.2.1 Corticosteroid Injections
  • 2.2.2 Hyaluronic Acid Injections
  • 2.2.3 Others
• 2.3 Joint Pain Injections Consumption by Type
  • 2.3.1 Global Joint Pain Injections Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Joint Pain Injections Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Joint Pain Injections Sale Price by Type (2014-2019)
• 2.4 Joint Pain Injections Segment by Application
  • 2.4.1 Hospital Pharmacies
  • 2.4.2 Retail Pharmacies
  • 2.4.3 Online Pharmacies
• 2.5 Joint Pain Injections Consumption by Application
  • 2.5.1 Global Joint Pain Injections Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Joint Pain Injections Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Joint Pain Injections Sale Price by Application (2014-2019)

3 Global Joint Pain Injections by Players

• 3.1 Global Joint Pain Injections Sales Market Share by Players
  • 3.1.1 Global Joint Pain Injections Sales by Players (2017-2019)
  • 3.1.2 Global Joint Pain Injections Sales Market Share by Players (2017-2019)
• 3.2 Global Joint Pain Injections Revenue Market Share by Players
  • 3.2.1 Global Joint Pain Injections Revenue by Players (2017-2019)
  • 3.2.2 Global Joint Pain Injections Revenue Market Share by Players (2017-2019)
• 3.3 Global Joint Pain Injections Sale Price by Players
• 3.4 Global Joint Pain Injections Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Joint Pain Injections Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Joint Pain Injections Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Joint Pain Injections by Regions

• 4.1 Joint Pain Injections by Regions
  • 4.1.1 Global Joint Pain Injections Consumption by Regions
  • 4.1.2 Global Joint Pain Injections Value by Regions
• 4.2 Americas Joint Pain Injections Consumption Growth
• 4.3 APAC Joint Pain Injections Consumption Growth
• 4.4 Europe Joint Pain Injections Consumption Growth
• 4.5 Middle East & Africa Joint Pain Injections Consumption Growth

5 Americas

• 5.1 Americas Joint Pain Injections Consumption by Countries
  • 5.1.1 Americas Joint Pain Injections Consumption by Countries (2014-2019)
  • 5.1.2 Americas Joint Pain Injections Value by Countries (2014-2019)
• 5.2 Americas Joint Pain Injections Consumption by Type
• 5.3 Americas Joint Pain Injections Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Joint Pain Injections Consumption by Countries
  • 6.1.1 APAC Joint Pain Injections Consumption by Countries (2014-2019)
  • 6.1.2 APAC Joint Pain Injections Value by Countries (2014-2019)
• 6.2 APAC Joint Pain Injections Consumption by Type
• 6.3 APAC Joint Pain Injections Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Joint Pain Injections by Countries
  • 7.1.1 Europe Joint Pain Injections Consumption by Countries (2014-2019)
  • 7.1.2 Europe Joint Pain Injections Value by Countries (2014-2019)
• 7.2 Europe Joint Pain Injections Consumption by Type
• 7.3 Europe Joint Pain Injections Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Joint Pain Injections by Countries
  • 8.1.1 Middle East & Africa Joint Pain Injections Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Joint Pain Injections Value by Countries (2014-2019)
• 8.2 Middle East & Africa Joint Pain Injections Consumption by Type
• 8.3 Middle East & Africa Joint Pain Injections Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Joint Pain Injections Distributors
• 10.3 Joint Pain Injections Customer

11 Global Joint Pain Injections Market Forecast

• 11.1 Global Joint Pain Injections Consumption Forecast (2019-2024)
• 11.2 Global Joint Pain Injections Forecast by Regions
  • 11.2.1 Global Joint Pain Injections Forecast by Regions (2019-2024)
  • 11.2.2 Global Joint Pain Injections Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Joint Pain Injections Forecast by Type
• 11.8 Global Joint Pain Injections Forecast by Application

12 Key Players Analysis

• 12.1 Allergan
  • 12.1.1 Company Details
  • 12.1.2 Joint Pain Injections Product Offered
  • 12.1.3 Allergan Joint Pain Injections Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Allergan News
• 12.2 Pfizer
  • 12.2.1 Company Details
  • 12.2.2 Joint Pain Injections Product Offered
  • 12.2.3 Pfizer Joint Pain Injections Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Pfizer News
• 12.3 Sanofi
  • 12.3.1 Company Details
  • 12.3.2 Joint Pain Injections Product Offered
  • 12.3.3 Sanofi Joint Pain Injections Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Sanofi News
• 12.4 Anika Therapeutics
  • 12.4.1 Company Details
  • 12.4.2 Joint Pain Injections Product Offered
  • 12.4.3 Anika Therapeutics Joint Pain Injections Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Anika Therapeutics News
• 12.5 Ferring
  • 12.5.1 Company Details
  • 12.5.2 Joint Pain Injections Product Offered
  • 12.5.3 Ferring Joint Pain Injections Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Ferring News
• 12.6 Bioventus
  • 12.6.1 Company Details
  • 12.6.2 Joint Pain Injections Product Offered
  • 12.6.3 Bioventus Joint Pain Injections Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Bioventus News
• 12.7 Flexion Therapeutics
  • 12.7.1 Company Details
  • 12.7.2 Joint Pain Injections Product Offered
  • 12.7.3 Flexion Therapeutics Joint Pain Injections Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Flexion Therapeutics News
• 12.8 Zimmer Biomet Holdings
  • 12.8.1 Company Details
  • 12.8.2 Joint Pain Injections Product Offered
  • 12.8.3 Zimmer Biomet Holdings Joint Pain Injections Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Zimmer Biomet Holdings News
• 12.9 SEIKAGAKU CORPORATION
  • 12.9.1 Company Details
  • 12.9.2 Joint Pain Injections Product Offered
  • 12.9.3 SEIKAGAKU CORPORATION Joint Pain Injections Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 SEIKAGAKU CORPORATION News
• 12.10 Chugai Pharmaceutical
  • 12.10.1 Company Details
  • 12.10.2 Joint Pain Injections Product Offered
  • 12.10.3 Chugai Pharmaceutical Joint Pain Injections Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Chugai Pharmaceutical News

13 Research Findings and Conclusion

Based on injection type, the global joint pain injections market has been segmented into corticosteroid injections, hyaluronic acid injections, and others. In terms of joint type, the global joint pain injections market has been divided into knee & ankle, hip joint, shoulder & elbow, facet joints of the spine, and others. Based on distribution channel, the market has been segregated into hospital pharmacies, retail pharmacies, and online pharmacies.

According to this study, over the next five years the Joint Pain Injections market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Joint Pain Injections business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Joint Pain Injections market by product type, application, key manufacturers and key regions and countries.

This study considers the Joint Pain Injections value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Corticosteroid Injections
Hyaluronic Acid Injections
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Allergan
Pfizer
Sanofi
Anika Therapeutics
Ferring
Bioventus
Flexion Therapeutics
Zimmer Biomet Holdings
SEIKAGAKU CORPORATION
Chugai Pharmaceutical

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Joint Pain Injections consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Joint Pain Injections market by identifying its various subsegments.
Focuses on the key global Joint Pain Injections manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Joint Pain Injections with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Joint Pain Injections submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.